RESUMO
BACKGROUND: Histoplasmosis caused by Histoplasma capsulatum var. duboisii (Hcd) is a rare, but probably underestimated, endemic infection described in intertropical Africa. Therefore, the epidemiology of the infection remains unclear, and there is no consensus on therapeutic management. METHODS: Using a comprehensive search on different Internet databases, we collected case reports of Hcd infection published from 1993 to 2019. Epidemiological and clinical charts and therapeutic strategies were analyzed. RESULTS: We found 94 well-documented cases of Hcd infection, and 30.1% of the patients were under 18 years old. Symptoms occurred in some patients several decades after leaving the endemic area. Cutaneous/subcutaneous lesions, bone infections, and lymphadenopathies, both isolated and combined, were the most frequent presentations. The human immunodeficiency virus (HIV) coinfection rate was at 20.8%, with fever, lymphadenopathies, and an absence of bone infection being the differentiating elements from patients living without HIV. The rate of disseminated forms (60.6% in our review) significantly increased as compared to studies published before 1993, but without correlation with HIV infection. The global mortality rate was at 23.4% by the end of follow-up. The outcome was not correlated with the antifungal drug prescribed, nor with HIV serologic status, but was correlated with the initiation of an antifungal therapy. CONCLUSIONS: Hcd histoplasmosis is a severe fungal infection for which the precise mode of acquisition remains to be determined. There is a need for affordable and more specific diagnostic tools. Itraconazole and amphotericin B are the best therapeutic alternatives and should be available in all low-income countries of the endemic area.
Assuntos
Infecções por HIV , Histoplasmose , Adolescente , África/epidemiologia , Infecções por HIV/complicações , Infecções por HIV/epidemiologia , Histoplasma , Histoplasmose/diagnóstico , Histoplasmose/tratamento farmacológico , Histoplasmose/epidemiologia , Humanos , Itraconazol/uso terapêuticoRESUMO
OBJECTIVE: To describe malaria during pregnancy outside endemic areas. MATERIALS AND METHODS: We retrospectively reviewed all cases of imported malaria during pregnancy, diagnosed over a 11-year period in a French hospital. RESULTS AND CONCLUSION: We recovered 18 cases, all from sub-Saharan countries. The infection could appear distantly from arrival in France (up to 36 months), was asymptomatic in 3 cases, with anemia being the most common marker of infection (n = 14). The adverse consequences for the fetus (n = 3) or the newborn (n = 4) were frequent. Physicians should be aware of these atypical presentations in order to anticipate the diagnosis and improve the maternal and fetal prognosis.
Assuntos
Doenças Transmissíveis Importadas/parasitologia , Malária/parasitologia , Complicações Parasitárias na Gravidez/parasitologia , Adulto , África Subsaariana , Doenças Transmissíveis Importadas/diagnóstico , Feminino , França , Humanos , Malária/diagnóstico , Gravidez , Complicações Parasitárias na Gravidez/diagnóstico , Estudos Retrospectivos , Adulto JovemRESUMO
Various infectious agents are classical risk factors for cancer including bacteria, viruses and parasites. There is less evidence concerning the implication of fungal infection in carcinogenesis. The role of chronic Candida infection in the development of squamous cell carcinoma has been suspected for years. Candida sp are more prevalent in potentially malignant disorder and cancer of the oral mucosa. Other epidemiological evidence of a link between Candida infection and cancer is what is observed in patients with Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED). Oral and oesophagal carcinoma are frequent in these patients with chronic mucocutaneous candidiasis. Production of nitrosamine and metabolism of procarcinogen are mecanisms in which Candida sp may be involved in oral cancer development. In chromomycosis and lobomycosis chronic lesions may have a risk of malignant transformation. A diagnosis of paracoccidioidomycosis appears to increase the risk of lung cancer.
Assuntos
Micoses/complicações , Neoplasias/microbiologia , Candidíase/complicações , Candidíase/epidemiologia , Candidíase/patologia , Candidíase Mucocutânea Crônica/complicações , Candidíase Mucocutânea Crônica/patologia , Carcinoma de Células Escamosas/microbiologia , Carcinoma de Células Escamosas/patologia , Transformação Celular Neoplásica/patologia , Neoplasias Esofágicas/microbiologia , Neoplasias Esofágicas/patologia , Humanos , Neoplasias Bucais/microbiologia , Neoplasias Bucais/patologia , Micoses/epidemiologia , Micoses/patologia , Neoplasias/epidemiologia , Neoplasias/patologia , Poliendocrinopatias AutoimunesAssuntos
Síndrome do Túnel Carpal/etiologia , Coriorretinite/etiologia , Dermatite/etiologia , Emigração e Imigração , Filariose/complicações , Prurido/etiologia , Viagem , Adulto , África , Idoso , Estudos de Coortes , Feminino , Filariose/diagnóstico , Filariose/fisiopatologia , França , Humanos , Loíase/complicações , Loíase/diagnóstico , Loíase/fisiopatologia , Masculino , Mansonelose/complicações , Mansonelose/diagnóstico , Mansonelose/fisiopatologia , Pessoa de Meia-Idade , Oncocercose/complicações , Oncocercose/diagnóstico , Oncocercose/fisiopatologia , Estudos Retrospectivos , Adulto JovemRESUMO
Mycetoma are chronic subcutaneous infections, endemic in dry tropical regions. It can be caused either by actinomycetes or by fungi, presenting as filamentous grains in vivo. The foot is the most common localization. The main complication is osseous involvement. Patients are rural workers living in areas situated far from medical centers. Too often, they reach well-equipped hospitals with advanced mutilating lesions. Early case detection is the first condition for good therapeutic results. Clinical presentations of actinomycetoma and eumycetoma are similar, only biological diagnosis can distinguish the two etiological forms. This distinction is essential as medical therapy for each is radically different. Precise identification of the causal agent is required for targeted treatment but it can only be realized in rare specialized laboratories. For actinomycetoma, standard therapy is trimethoprim-sulphamethoxazole (STX). Duration of treatment period is one-year minimum. In case of poor response to STX or high risk of dissemination, a combination with amikacin gave high cure rate. Other options as amoxicillin-clavulanate are available. Medical cure of actinomycetoma is generally obtained with antibiotic treatments and surgical indications are exceptional. Disappointing results were observed using antifungal in the treatment of eumycetoma and medical therapy must be completed with surgical excision. Itraconazole is now the most used drug, new triazoles are on evaluation.
Assuntos
Antifúngicos/uso terapêutico , Micetoma/tratamento farmacológico , Micetoma/microbiologia , Actinobacteria/efeitos dos fármacos , Actinobacteria/patogenicidade , Antifúngicos/classificação , Doença Crônica , Humanos , Itraconazol/uso terapêutico , Combinação Trimetoprima e Sulfametoxazol/uso terapêuticoRESUMO
OBJECTIVE OF THE STUDY: Mycetomas are chronic sub-cutaneous tropical infections in which exogenous causative agents, fungal (eumycetes) or bacterial (actinomycetes), generate grains. The typical presentation is multi-fistulized pseudotumors. This disease, particularly eumycetoma, is difficult to treat. It is a major health problem in tropical and subtropical countries. In France, the disease is rare, but patients have access to a broader range of treatments. The authors had for objective to present the cases of mycetomas diagnosed in developed country and their management. PATIENTS AND METHODS: A retrospective study was made on the clinical presentation and management of mycetomas from 1995 to 2011, in the Bobigny Avicenne teaching hospital. RESULTS: Six patient files were studied. The patients were men with a median age of 31 years (16-70). Five patients were from Sub Saharan Africa, one from Sri Lanka. The etiologies were one actinomycetoma and five eumycetomas. There was bone involvement in five cases. There was one atypical presentation: a primary intra-osseous mycetoma. Three patients were cured including two by surgical management and one by medical treatment (actinomycetoma). Antifungal therapy failed (four patients) in every case (voriconazole, itraconazole, ketoconazole, terbinafine, caspofungin). CONCLUSION: The results of this study made in a non-epidemic zone revealed that despite a typical clinical presentation, the diagnosis and management were delayed because this imported disease is rare in France. The patients received new broad-spectrum triazole and caspofungin, but none were cured with antifungal therapy alone.
Assuntos
Emigrantes e Imigrantes , Micetoma/tratamento farmacológico , Adolescente , Adulto , África Subsaariana/etnologia , Idoso , Antibacterianos/uso terapêutico , Antifúngicos/uso terapêutico , Países Desenvolvidos , Gerenciamento Clínico , Dermatoses do Pé/diagnóstico , Dermatoses do Pé/tratamento farmacológico , Dermatoses do Pé/etnologia , Dermatoses do Pé/cirurgia , França/epidemiologia , Humanos , Masculino , Pessoa de Meia-Idade , Micetoma/diagnóstico , Micetoma/etnologia , Micetoma/cirurgia , Nocardiose/diagnóstico , Nocardiose/tratamento farmacológico , Estudos Retrospectivos , Sri Lanka/etnologia , Resultado do Tratamento , Adulto JovemRESUMO
In recent days immigrants represent the main risk group for imported malaria in northern countries. Most of them are migrants returning to their country of origin to visit friends and relatives (VFR). We retrospectively examined the main clinical, biological, and therapeutic data of all malaria cases in immigrants from 2006 to 2010 in Tenon hospital, Paris. The hospital is situated in a Paris district with an important African community. During the study period 239 imported malaria cases were observed in adults of which 199 were immigrants, 186 VFR, and 13 recently arrived. Most cases were from sub-Saharan Africa and Comoro islands. Chimioprophylaxis was not taken in 81.2% of VFR. It was inadequate in 43.7% and not taken correctly in 84.4%. Plasmodium falciparum was the most frequent species identified: 190/199 (95.5%). Severe P. falciparum malaria was observed in 25 cases (13.2%); two of them were recently arrived. One patient, African VFR, died. In this series two high-risk groups were represented: HIV-infected patients and pregnant women. Six of the HIV patients had severe malaria and all pregnant women had anemia. Our results are similar to those observed recently in other European countries. Mean age of VFR is increasing and the risk for severe P. falciparum malaria became identical to the one observed in non-immune travelers. Protection measures remain still insufficient in this population of travelers.
Assuntos
Emigrantes e Imigrantes/estatística & dados numéricos , Malária/epidemiologia , Adolescente , Adulto , África Subsaariana/etnologia , Idoso , China/etnologia , Comores/etnologia , Família , Feminino , Amigos , Haiti/etnologia , Hospitais/estatística & dados numéricos , Humanos , Malária/etnologia , Malária/transmissão , Masculino , Pessoa de Meia-Idade , Paris/epidemiologia , Gravidez , Estudos Retrospectivos , Viagem/estatística & dados numéricos , Adulto JovemAssuntos
Dermatoses Faciais/microbiologia , Laringite/microbiologia , Micoses/microbiologia , Penicillium/isolamento & purificação , Úlcera Cutânea/microbiologia , Adulto , Biópsia , Candidíase Cutânea/diagnóstico , Diagnóstico Diferencial , Dermatoses Faciais/complicações , Feminino , Glomerulonefrite/complicações , Hemoglobina E , Hemoglobinúria/complicações , Histoplasmose/diagnóstico , Humanos , Hospedeiro Imunocomprometido , Laos/etnologia , Laringite/complicações , Laringite/patologia , Micologia/métodos , Micoses/complicações , Micoses/diagnóstico , Penicillium/classificação , Penicillium/patogenicidade , Úlcera Cutânea/complicações , Especificidade da Espécie , Coloração e Rotulagem/métodos , Tailândia , ViagemRESUMO
Leptosphaeria tompkinsii is a dematiaceous fungus which is rarely reported as an agent of black-grain mycetoma. We present a case involving a mycetoma of the hand of a former farmer from Mali, West Africa, who has been a resident in France for 27 years. The patient was successfully treated with surgery and the use of oral itraconazole for 6 months. Species identification was based on sexual reproductive structures observed on potato-carrot agar media and the use of internal transcribed spacer sequencing.
Assuntos
Ascomicetos/isolamento & purificação , Micetoma/diagnóstico , Adulto , Agricultura , Antifúngicos/administração & dosagem , Ascomicetos/classificação , Desbridamento , Mãos/microbiologia , Mãos/patologia , Humanos , Itraconazol/administração & dosagem , Masculino , Mali , Microscopia , Micetoma/tratamento farmacológico , Micetoma/microbiologia , Micetoma/cirurgia , Micologia/métodosRESUMO
Diagnosis of strongyloidiasis using stool examination remains unsatisfactory due to the lack of sensitivity and fastidious techniques. In this work, we investigated the value of an anti-Strongyloides IgG enzyme immunoassay (EIA), using a panel of 207 sera retrospectively collected from patients with definitive diagnoses of strongyloidiasis (n=57), other helminthic infections (n=46), eosinophilia without parasitic infection diagnosis (n=54), and digestive disturbances following a tropical journey (n=30) and from 20 negative controls. By following a receiver operating characteristic (ROC) curve analysis, it was possible to optimize the test to reach a sensitivity of 91.2% and a specificity of 93.3%, with 92.8% of patients correctly classified. Considering the incidence of strongyloidiasis diagnosed in our own laboratory, the negative predictive value was calculated at 99.9%. In conclusion, this test is very rapid and easy to perform and may be valuable for diagnosis of strongyloidiasis both in cases where the infection is unrevealed by a parasitological stool examination and in patients at risk for severe clinical forms, such as patients receiving immunosuppressive therapy.
Assuntos
Anticorpos Anti-Helmínticos/sangue , Imunoglobulina G/sangue , Parasitologia/métodos , Strongyloides/imunologia , Estrongiloidíase/diagnóstico , Animais , Ensaio de Imunoadsorção Enzimática/métodos , Humanos , Valor Preditivo dos Testes , Curva ROC , Sensibilidade e Especificidade , Fatores de TempoRESUMO
This article describes the first cases of imported Chagas' disease detected in Paris, France. A total of 18 cases were recorded in two teaching hospitals between 2004 and 2007. There were 12 women and six men with a mean age of 38 years. All patients were Latin American immigrants who had recently arrived in France from Bolivia (Cochabamba and Santa-Cruz departments) 17 cases and from Salvador in 1. Eleven patients presented an asymptomatic indeterminate form of the chronic disease. Seven presented chronic Chagas cardiomyopathy including two with severe symptoms requiring placement of a pacemaker. Obtaining serological tests to confirm the diagnosis was difficult. All except one patient who was older than 50 years were treated with benznidazole. Based on these findings, the main priorities for management imported Chagas' disease in France are improvement of serological diagnosis and prevention of vertical transmission.
Assuntos
Doença de Chagas/epidemiologia , Doenças Transmissíveis Emergentes/epidemiologia , Adulto , Emigrantes e Imigrantes , Feminino , França , Humanos , América Latina/etnologia , Masculino , Pessoa de Meia-IdadeRESUMO
In routine laboratory practice, the determination of MICs of antifungals for yeasts often relies on the Etest, because of a good correlation with reference methods. However, this correlation was established through predesigned studies, rather than prospective testing. The surveillance programme of fungaemia (YEASTS programme), implemented since 2003, facilitated our comparison of the Etest and the EUCAST results, obtained on a routine basis in nine different hospitals and in a reference laboratory, respectively. The analysis included 690 isolates recovered from blood culture (362 Candida albicans, 113 Candida glabrata, 69 Candida parapsilosis, 55 Candida tropicalis, 31 Cryptococcus neoformans, and 60 other yeast species) that were tested for their susceptibility to amphotericin B (n = 655), fluconazole (n = 669), itraconazole (n = 198), voriconazole (n = 588), flucytosine (n = 314), and caspofungin (n = 244). Agreement between the Etest and EUCAST datasets was calculated and categorized on the basis of previously published breakpoints. The level of agreement at ±2 dilutions was 75% for amphotericin B and 90% for flucytosine; for the azoles, it ranged from 71% for itraconazole to 87% for voriconazole. No significant difference was observed among the yeast species, except for Cryptococcus neoformans and flucytosine, with an agreement <40%. Categorical agreement ranged from 60% for itraconazole to 90% for flucytosine. Major and very major discrepancies occurred in <12% and 6%, respectively. The Etest, even when performed on a routine basis, shows a ≥71% agreement with the EUCAST reference method.
Assuntos
Antifúngicos/farmacologia , Testes de Sensibilidade Microbiana , Leveduras/efeitos dos fármacos , Anfotericina B/farmacologia , Candida/efeitos dos fármacos , Candida/isolamento & purificação , Caspofungina , Cryptococcus neoformans/efeitos dos fármacos , Cryptococcus neoformans/isolamento & purificação , Farmacorresistência Fúngica , Equinocandinas/farmacologia , Fluconazol/farmacologia , Flucitosina/farmacologia , Fungemia , Itraconazol/farmacologia , Laboratórios Hospitalares , Lipopeptídeos , Pirimidinas/farmacologia , Valores de Referência , Triazóis/farmacologia , VoriconazolRESUMO
Chagas disease (human American trypanosomiasis) is a zoonose caused by the protozoan Trypanosoma cruzi. Vectors are Triatoma spp. insects. T. cruzi can also be transmitted by blood transfusion, organ transplantation, and transplacentally. Infection is generally acquired during infancy. The acute infection is rarely symptomatic and is followed by a chronic phase. Chronic infected people are asymptomatic (indeterminate stage) and may remain at this stage for the rest of their lives. About a third of infected people will develop a chronic Chagas disease which affects the heart and the digestive tract. Morbidity and mortality of chronic Chagas cardiomyopathy (CCC) are high. Specific treatment of asymptomatic infected individual could reduce the risk of progression to CCC. With control initiatives case incidence declined in most endemic countries. American trypanosomiasis has become an emerging imported disease in North America and Europe because of the migration of population originating from endemic zones. They are only two available drugs for specific treatment of Chagas disease: benznidazole and nifurtimox. Both have frequent side effects and variable efficacy according the phase of the disease. There is an urgent need for new treatments and better serological tests. Policies must be developed to avoid the risk of transmission trough blood transfusion and transplantation in developed countries.
Assuntos
Doença de Chagas/tratamento farmacológico , Doença de Chagas/transmissão , Animais , Doença de Chagas/diagnóstico , Doença de Chagas/epidemiologia , Emigração e Imigração , Humanos , Insetos Vetores , Nifurtimox/uso terapêutico , Nitroimidazóis/uso terapêutico , Tripanossomicidas/uso terapêuticoRESUMO
2009 is marked by the centenary of the discovery by Carlos Chagas of Human American Trypanosomiasis. As a result of international cooperation its incidence has been falling in endemic areas, whereas North America and Europe are witnessing an increase in the number of imported cases. In metropolitan France, 18 such cases were reported between 2004 and 2007. Recently, estimates based on immigration figures have been made and suggest that about 1,500 imported cases can be expected in France. The object of this article is to assess the value of targeted screening of an at-risk population, originally from Latin America and now living in the Ile-de-France (area centred on Paris). The serological techniques employed were indirect immunofluorescence (IIF) and, depending on the case, 2 or 3 Elisa tests (Biomérieux, Biokit and Wiener). Trypanosoma cruzi serology was considered positive when the IIF was superior or equal to 200, or when two Elisa's were > 1, or when the IIF was superior or equal to 100 with at least one Elisa > 1. PCR was performed in 48 cases, which were considered to be positive. The tests were carried out on a voluntary basis after a publicity campaign within the Latin American community in the Ile-de-France. In this article, we present the findings of the first year of screening. Two hundred and fifty-four individuals were screened for Chagas' disease between June 2008 and June 2009. The median age was 33 years [11-63], the male/female ratio 102/152. Overall prevalence of positive serology was 23.6% (60/254). For six patients, the results were classified as "uncertain" (discordant serological tests). Of the seropositive group, 87.4% were Bolivian and 100% presented as a chronic form. Of these, 23.6% presented with functional cardiac manifestations and 22% with gastro-intestinal problems. The PCR was positive in 61% of the seropositive individuals. Clinical evaluation together with other investigations and therapeutic intervention is being carried out at present. These results confirm that metropolitan France is subject to the emergence of Chagas' disease in a non-endemic zone. This confirms the value of screening in at-risk populations, in particular because of the recent broadening of indications for antiparasitic treatment. In addition it is relevant to the prevention of vertical transmission or infection via organ donation, which could arise in France. These results also demonstrate continuing difficulties in the interpretation of serological results and the usefulness of PCR, which might increase sensitivity substantially.
Assuntos
Doença de Chagas/diagnóstico , Animais , Brasil/epidemiologia , Doença de Chagas/epidemiologia , Doença de Chagas/prevenção & controle , Emigração e Imigração/estatística & dados numéricos , Europa (Continente)/epidemiologia , Humanos , Programas de Rastreamento/métodos , América do Norte/epidemiologia , Paris/epidemiologia , Prevalência , Trypanosoma cruzi/isolamento & purificaçãoRESUMO
Ciguatera is a toxic poisoning due to ingestion of fish and is rarely reported in France. Little is known about this imported tropical disease. We present a case observed in Paris in a traveller returning from the Dominican Republic.
Assuntos
Ciguatera/diagnóstico , Ciguatera/terapia , Viagem , Adulto , França , Humanos , MasculinoRESUMO
In the Democratic Republic of Congo (DRC), as in many African countries, AIDS and its procession of opportunistic infections are a major cause of morbidity and mortality. In Kinshasa, the estimated prevalence rate of HIV-infected persons is between 4 and 5%, corresponding to more than 200,000 people. Due to the lack of trained laboratory personnel and appropriate diagnostic equipment, no local investigation has been carried out to determine the prevalence of the opportunistic digestive parasitic infection in HIV-infected persons. As a step to obtaining this information that is needed for implementation of an adequate care policy, a preliminary investigation was carried out in Paris, France on 50 stool samples from 50 AIDS-patients hospitalized in 3 reference hospitals in Kinshasa. Eleven patients (22%) had digestive symptoms with a diarrhea syndrome. Further study using specialized techniques demonstrated 2 cases of digestive infection related to opportunistic parasites (4%). The first involved a Cryptosporidium sp. The second represented the first case of Enterocytozoon bieneusi infection reported in the literature from the DRC.
Assuntos
Infecções Oportunistas Relacionadas com a AIDS/epidemiologia , Enteropatias Parasitárias/epidemiologia , Infecções Oportunistas Relacionadas com a AIDS/parasitologia , Adulto , República Democrática do Congo/epidemiologia , Diarreia/parasitologia , Feminino , Humanos , Enteropatias Parasitárias/parasitologia , Masculino , Pessoa de Meia-Idade , PrevalênciaRESUMO
We report a case of cutaneous gnathostomiasis acquired in Myanmar where this parasitic zoonosis was considered as non-endemic until a recent outbreak. Myanmar must be added to the list of countries where the infection can be acquired in Southeast Asia. Despite a treatment with ivermectin the patient relapsed after an apparent cure. A double-dose of ivermectin is now recommended for the treatment of gnathostomiasis.